U.K. Warns Of Antipsychotic Stroke Risk In Elderly Patients
This article was originally published in The Pink Sheet Daily
The Committee on Safety of Medicines cautions against use of risperidone and olanzapine to treat behavioral disturbances associated with dementia.
You may also be interested in...
"Dear Doctor" letter calls attention to clinical trial data showing increased incidence of mortality and cerebrovascular events compared to placebo. Lilly has discontinued studying Zyprexa in elderly patients with dementia.
A possible settlement between Merck and tax authorities could be significantly smaller than GlaxoSmithKline's recent settlement with the IRS based on the companies' projected liability
Pfizer's success will depend on its ability to negotiate the paradox of increasing demand for pharmaceuticals coupled with growing attempts to restrain costs, CEO Jeffrey Kindler said